Skip to main content
CI
NYSE Finance

Cigna Beats Q3, Lifts 2026 Guidance, but Flags 2027 Rebate and GLP-1 Headwinds

Tom Rudovsky · Reported by Benzinga
More coverage: Financial
Sentiment info
Positive
Importance info
7
Price
$302.34
Mkt Cap
$79.89B
52W Low
$255.528
52W High
$318.05
52W Position info
18% above low
Off High info
4.9% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

CI sits 18% above its 52-week low of $255.528.

Summary

Cigna beat on both lines: adjusted EPS of $7.98 versus $7.50 consensus and revenue of $73.683 billion, up 6% year over year and ahead of the $72.720 billion expected. It raised 2026 adjusted earnings guidance to at least $30.60 a share from at least $30.45, and narrowed its 2026 medical care ratio outlook to 84.2% plus or minus 25 basis points. The stock is trading slightly lower, and the reason is 2027: management flagged shrinking industry rebate pools, lower employer coverage of GLP-1 weight-loss drugs at Evernorth's PBM, fewer biosimilar and specialty generic launches, and the previously announced ACA Exchange exit removing that revenue. Offsetting that, Cigna still expects at least 10% adjusted EPS growth in 2027, backed by better stop-loss margins, a strong selling season and savings from its Accelerate to One productivity program. Membership is the soft spot — total customer relationships fell 6% to 177.6 million, with behavioral customers down 19% to 23 million after a government contract ended, while medical customers rose 2% to 18.5 million.

At the time of this announcement, CI was trading at $302.34 on NYSE in the Finance sector, with a market capitalization of approximately $79.9B. The 52-week trading range was $255.53 to $318.05. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Benzinga.


Price Chart

Share this article

Copied!

CI - Latest Insights

CI
Nov 05, 2026, 11:07 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $312.17
Real-time Price: $271.00 info
Change: -$41.17 (-13%) info
Market Cap: $71.388B info
CI
Nov 05, 2026, 6:51 AM EST
Source: dpa-AFX
Importance Score:
7
Price at Filing: $307.26
Real-time Price: $271.00 info
Change: -$36.26 (-12%) info
Market Cap: $71.388B info
CI
Nov 05, 2026, 6:15 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $307.26
Real-time Price: $271.00 info
Change: -$36.26 (-12%) info
Market Cap: $71.388B info
CI
Nov 05, 2026, 6:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $300.90
Real-time Price: $271.00 info
Change: -$29.90 (-10%) info
Market Cap: $71.388B info
CI
Oct 01, 2026, 3:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $271.83
Real-time Price: $271.00 info
Change: -$0.830 (-0.31%) info
Market Cap: $71.388B info